Wieslab, a Svar Life Science company, is a contract laboratory that offers large molecule bioanalytical services to support drug development projects. The company specializes in pharmacokinetics (PK), immunogenicity, biomarker and cell-based services for clinical applications ranging from pre-clinical to Phase I-III trials. As a Svar Life science company, Wieslab has direct access to state-of-the-art iLite® technology, which is based upon reporter-gene cell-based assays. This is used to assess neutralising antibodies. Wieslab works within oncology and immune-mediated drug development projects. Its laboratory meets good clinical practice (GCP), good laboratory practice (GLP) and ISO15189 requirements, and its staff are experienced at working in regulated environments. - Developing, optimizing and validating sensitive and robust immunoassays - Pharmacokinetic testing to increase drug efficacy - Immunogenicity testing to measure ADAs and NAbs - Biomarker services using ELISA or electrochemiluminescence - Cell-based services - Project management services The scientific knowledge of our staff makes a key difference to our client’s projects. More than 50% have a Doctorate (PhD), and the company works to stay up-to-date with the latest regulatory guidelines and scientific development. The majority of the company personnel has worked within the pharmaceutical or biotech industries, with experience in delivering high-quality data and working according to applicable guidelines and regulations. Wieslab has a flexible team of scientists that work closely with sponsors to adapt to changing requirements and to speed up the development process.